Yearly Alterations in Prognostic Factors in Gastric Cancer during the Post-operative Period

Anticancer Research

Volumn 24, Issue 1, 2004, Pages 377-383

  Kunisaki, Chikara ^a   Shimada, Hiroshi ^a   Akiyama, Hirotoshi ^a   Nomura, Masato ^a   Matsuda, Goro ^a   Otsuka, Yuichi ^a   Ono, Hidetaka ^a  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

Author keywords

Gastric cancer; Prognostic factors

Indexed keywords

ADULT; AGE; AGED; ARTICLE; CANCER RECURRENCE; CANCER STAGING; CAUSE OF DEATH; FEMALE; GASTRECTOMY; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; PERITONEUM METASTASIS; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; STOMACH CANCER; TUMOR VOLUME;

CAUSE OF DEATH; FEMALE; GASTRECTOMY; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; POSTOPERATIVE PERIOD; PROGNOSIS; RETROSPECTIVE STUDIES; STOMACH NEOPLASMS;

EID: 1442277054     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Wanebo HJ, Kennedy BJ, Chmiel G Jr, Winchester D and Osteen R: Cancer of the stomach. A patient care study by the American College of Surgeons. Ann Surg 218: 583-592, 1993.
2. Akoh JA and Macintyre IMC: Improving survival in gastric cancer: review of 5-year survival rates in English language publications from 1970. Br J Surg 79: 293-299, 1992.
3. Moriguchi S, Maehara Y, Korenaga D, Kakeji Y, Sugimachi K and Nose Y: The relationship between prognostic significance of pathological type and the degree of gastric wall invasion in gastric cancer. Cancer J 5: 220-223, 1992.
4. Tsujitani S, Oka S, Suzuki K, Saito H, Kondo A, Ikeguchi M et al: Prognostic factors in patients with advanced gastric cancer treated by noncurative resection: A multivariate analysis. Hepato-Gastroenterol 48: 1504-1508, 2001.
5. Kinugasa S, Abe S, Tachibana M, Yoshimura H, Monden N, Dhar DK et al: Surgically curable and incurable scirrhous carcinomas of the stomach. J Surg Oncol 65: 194-200, 1997.
6. Fujimoto S, Shrestha RD, Kokubun M, Ohta M, Takahashi M, Kobayashi K et al: Intraperitoneal hyperthermic perfusion combined with surgery effective for gastric cancer patients with peritoneal seeding. Ann Surg 208: 36-41, 1988.
7. Fujimura T, Yonemura Y, Fushida S, Urade M, Takegawa S, Kamata T et al: Continuous hyperthermic peritoneal perfusion for the treatment of peritoneal dissemination in gastric cancers and subsequent second-look operation. Cancer 65: 65-71, 1990.
8. Annie CB, Olivier G, Jean LC, Yves F, Jacques B, Gilles P et al: Intraperitoneal chemohyperthermia with mitomycin C for digestive tract cancer patients with peritoneal carcinomatosis. Cancer 85: 2512-2519, 2000.
9. Paul HS and Yutaka Y: Clinical pathway for the management of resectable gastric cancer with peritoneal seeding: best palliation with a ray of hope for cure. Oncology 58: 96-107, 2000.
10. Kunisaki C, Shimada H, Nomura M, Akiyama H, Takahashi M and Matsuda G: Lack of efficacy of prophylactic continuous hyperthermic peritoneal perfusion on subsequent peritoneal recurrence and survival in patients with advanced gastric cancer. Surgery 131: 521-528, 2002.
11. Osugi H, Takada N, Takemura M, Kaseno S, Lee S, Ueno M et al: Oral fluoropyrimidine anticancer drug TS-1 for gastric cancer patients with peritoneal dissemination. Oncol Rep 9: 811-815, 2002.
12. Japanese Research Society for Gastric Cancer. Japanese Classification of Gastric Carcinoma 1st Edition. Tokyo, Kanehara & Co., Ltd., 1998
13. Roder JD, Bottcher K, Siewert JR, Busch R, Hermanek P and Meyer HJ: Prognostic factors in gastric carcinoma. Results of the German Gastric Carcinoma Study 1992. Cancer 72: 2089-2097, 1993.
14. Siewert JR, Bottcher K, Stein H and Roder JD: Relevant prognostic factors in gastric cancer. Ten-year results of the German Gastric Cancer Study. Ann Surg 228: 449-461, 1998.
15. Kunisaki C, Shimada H, Takahashi M, Ookubo K, Moriwaki Y, Akiyama H et al.: Prognostic factors in early gastric cancer. Hepato-Gastroenterol 48: 294-298, 2001.
16. Kim JP, Kin Y, Yang HK and Noh DY: Significant prognostic factors by multivariate analysis of 3926 gastric cancer patients. World J Surg 18: 872-878, 1994.
17. Sanchez-Bueno F, Garcia-Marcilla JA, Perez-Flores D, Perez-Abad JM, Vincente R, Aranda F et al: Prognostic factors in a series of 297 patients with gastric adenocarcinoma undergoing surgical resection. Br J Surg 85: 255-260, 1998.
18. Starzynska T, Markiewski M, Domagala W, Marlicz K, Mietkiewski J, Roberts SA et al: The clinical significance of p53 accumulation in gastric carcinoma. Cancer 77: 2005-2012, 1996.
19. Park TJ, Han SU, Cho YK, Paik WK, Kim YB and Lim IK: Methylation of O (6)-methylguanine-DNA methyltransferase gene is associated significantly with K-ras mutation, lymph node invasion, tumor staging and disease free survival in patients with gastric carcinoma. Cancer 92: 2760-2768, 2001.
20. Russo A, Bazan V, Migliavacca M, Tubiolo C, Macaluso M, Zanna I et al: DNA aneuploidy and high proliferative activity but not K-ras-2 mutations as independent predictors of clinical outcome in operable gastric carcinoma. Cancer 92: 294-302, 2001.
21. Liu XP, Tsushimi K, Tsushimi M, Kawauchi S, Oga A, Furuya T et al: Expression of p21 (WAF1/CIP1) and p53 proteins in gastric carcinoma: its relationships with cell proliferation activity and prognosis. Cancer Lett 170: 183-189, 2001.
22. Baldus SE, Zirbes TK, Glossmann J, Fromm S, Hanisch FG et al: Immunoreactivity of monoclonal antibody bw835 represents a marker of progression and prognosis in early gastric cancer. Oncology 61: 147-155, 2001.
23. Kunisaki C, Shimada H, Yamaoka H, Wakasugi J, Takahashi M, Akiyama H et al: Significance of para-aortic lymph node dissection in advanced gastric cancer. Hepato-Gastroenterol 46: 2635-2642, 1999.
24. Kunisaki C, Shimada H, Yamaoka H, Takahashi M, Ookubo K, Akiyama H et al: Indications for para-aortic lymph node dissection in gastric cancer patients with para-aortic lymph node involvement. Hepato-Gastroenterol 47: 586-589, 2000.
25. Moriwaki Y, Kobayashi S, Harada H, Kunisaki C, Imai S, Kido Y et al: Risk factors for the recurrence of gastric cancer patients in various periods after operation. Jpn J Gastroenterol Surg 31: 21-26, 1998.